# FDA Inspection 1323212 - Linde Inc. - June 11, 2026

Source: https://www.keypedia.com/records/fda_inspections/linde-inc/51b9a56f-72ff-47f5-befd-b74e80fc1c20
Source feed: FDA_Inspections

> FDA Inspection 1323212 for Linde Inc. on June 11, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1323212
- Company Name: Linde Inc.
- Inspection Date: 2026-06-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 888333 - 2014-07-24](https://www.keypedia.com/records/fda_inspections/linde-inc/fa8c59ea-994b-4a31-975b-7f4030cbf812)

Company: https://www.keypedia.com/companies/linde-inc/ef6ae34a-687f-4c83-9f1a-bec2b56f74ff

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c